[go: up one dir, main page]

DE69633557D1 - Imdazol-derivate, deren herstellung und deren verwendung als s-adenosylmethionin decarboxylase (=samdc) inhibitoren - Google Patents

Imdazol-derivate, deren herstellung und deren verwendung als s-adenosylmethionin decarboxylase (=samdc) inhibitoren

Info

Publication number
DE69633557D1
DE69633557D1 DE69633557T DE69633557T DE69633557D1 DE 69633557 D1 DE69633557 D1 DE 69633557D1 DE 69633557 T DE69633557 T DE 69633557T DE 69633557 T DE69633557 T DE 69633557T DE 69633557 D1 DE69633557 D1 DE 69633557D1
Authority
DE
Germany
Prior art keywords
hydrogen
pct
samdc
imdazol
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69633557T
Other languages
English (en)
Other versions
DE69633557T2 (de
Inventor
Joerg Frei
Jaroslav Stanek
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Publication of DE69633557D1 publication Critical patent/DE69633557D1/de
Application granted granted Critical
Publication of DE69633557T2 publication Critical patent/DE69633557T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/88—Nitrogen atoms, e.g. allantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical
    • C07D233/46—Nitrogen atoms not forming part of a nitro radical with only hydrogen atoms attached to said nitrogen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE69633557T 1995-01-26 1996-01-15 Imdazol-derivate, deren herstellung und deren verwendung als s-adenosylmethionin decarboxylase (=samdc) inhibitoren Expired - Lifetime DE69633557T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH21595 1995-01-26
CH21595 1995-01-26
PCT/EP1996/000143 WO1996022979A1 (en) 1995-01-26 1996-01-15 Imidazole derivatives, their preparation and their use as s-adenosylmethionine decarboxylase (=samdc) inhibitors

Publications (2)

Publication Number Publication Date
DE69633557D1 true DE69633557D1 (de) 2004-11-11
DE69633557T2 DE69633557T2 (de) 2005-10-13

Family

ID=4181898

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69633557T Expired - Lifetime DE69633557T2 (de) 1995-01-26 1996-01-15 Imdazol-derivate, deren herstellung und deren verwendung als s-adenosylmethionin decarboxylase (=samdc) inhibitoren

Country Status (9)

Country Link
US (1) US5840911A (de)
EP (1) EP0808309B1 (de)
JP (1) JP3989543B2 (de)
AT (1) ATE278676T1 (de)
AU (1) AU4486796A (de)
CA (1) CA2210533C (de)
DE (1) DE69633557T2 (de)
ES (1) ES2229260T3 (de)
WO (1) WO1996022979A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4437399A (en) 1998-06-12 1999-12-30 Waters Investments Limited Novel ion exchange porous resins for solid phase extraction and chromatography
US20030224970A1 (en) * 2002-05-17 2003-12-04 Sanjoy Mahanty Methods for the identification of inhibitors of S-adenosylmethionine decarboxylase as antibiotics
US7264819B2 (en) * 2003-06-23 2007-09-04 Anticancer, Inc. Lyase treatment for P. carinii
CN106389399B (zh) * 2016-04-22 2019-02-19 三峡大学 一种小分子共价抑制剂在制备抑制s-腺苷甲硫氨酸脱羧酶的药物上的应用及其筛选方法
CN106389415B (zh) * 2016-04-22 2019-02-19 三峡大学 小分子共价抑制剂在制备抑制s-腺苷甲硫氨酸脱羧酶的药物上的应用及其筛选方法
CN106389403B (zh) * 2016-04-22 2019-02-19 三峡大学 小分子共价抑制剂在制备抑制s-腺苷甲硫氨酸脱羧酶的药物上的应用及筛选方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4659720A (en) * 1982-12-20 1987-04-21 Merck & Co., Inc. 5-amino or substituted amino imidazoles useful to treat coccidiosis
CA1332572C (en) * 1988-01-29 1994-10-18 Anthony Cerami Method and agents for preventing staining of teeth
US4971986A (en) * 1988-03-25 1990-11-20 Ciba-Geigy Corporation Arylhydrazones useful as SAMDC inhibitors
AU645799B2 (en) * 1990-05-07 1994-01-27 Novartis Ag Hydrazones
RU2081108C1 (ru) * 1991-10-16 1997-06-10 Циба-Гейги АГ Аддитивные соли кислот с основанием и фармацевтическая композиция, обладающая противоопухолевой активностью

Also Published As

Publication number Publication date
WO1996022979A1 (en) 1996-08-01
ES2229260T3 (es) 2005-04-16
ATE278676T1 (de) 2004-10-15
AU4486796A (en) 1996-08-14
US5840911A (en) 1998-11-24
EP0808309A1 (de) 1997-11-26
EP0808309B1 (de) 2004-10-06
DE69633557T2 (de) 2005-10-13
CA2210533C (en) 2007-12-04
CA2210533A1 (en) 1996-08-01
JPH10512578A (ja) 1998-12-02
JP3989543B2 (ja) 2007-10-10

Similar Documents

Publication Publication Date Title
TR200002606T2 (tr) Benzen-sülfonamit türevleri ve ilaç olarak kullanımları.
MY101208A (en) Phenyl-piperazine anti-arrhythmia agents.
MX9203762A (es) Administracion de monoaminacridinas en estados deficientes en colinergicos-neuronales.
TR199700827A2 (xx) Fenil'le s�bstit�e edilmi� alkenil karbonik asitguanidin'leri.
ATE181731T1 (de) Isothioharnstoff-derivate als no synthase hemmer
ATE72431T1 (de) 5-gliedrige heterocyclische angiotensinumwandlungsenzym-inhibitoren.
ID26622A (id) Senyawa-senyawa pengganti 2-benzylamino-2-phenyl-acetamide
DK0572635T3 (da) Hidtil ukendte forbindelser med guanidinstruktur og farmaceutisk komposition indeholdende forbindelserne
DE69633557D1 (de) Imdazol-derivate, deren herstellung und deren verwendung als s-adenosylmethionin decarboxylase (=samdc) inhibitoren
NO972938D0 (no) Farmasöytiske piperazinforbindelser
ATE13765T1 (de) 2-(1,4-benzodioxan-2-ylalkyl)-imidazole, deren herstellung und sie enthaltende pharmazeutische mittel.
FR2549049B1 (fr) Nouvelles amidines, leur procede de preparation et leur application therapeutique
NO167746C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive muramylpeptidderivater.
DE69104475D1 (de) Harnstoffderivate, ihre herstellung und deren enthaltende arzneimittel.
DK0456133T3 (da) Hydrazoner
DE69431471D1 (de) Amide derivate als 5-ht1a liganden
DK0706517T3 (da) Pyridazinonderivater med farmaceutisk virkning
SE8303913D0 (sv) Heterocykliska foreningar
DE3572808D1 (en) 4-(nitrophenyl)-tetrahydropyridines, process for their preparation and their application as pharmaceutical compounds
TR199701289T2 (xx) Karbapenemlerin esterleri
DK0687257T3 (da) 4-amino-2-(hetero)aryl-butanamider anvendelige som 5HT1A-antagonister
FR2665442B1 (fr) Derives d'alkyl-6 pyridazine, procede de preparation et compositions pharmaceutiques en contenant.
FR2695643B1 (fr) Dérivés d'uréido-acétamide, leur préparation et les médicaments les contenant.
ATE44741T1 (de) 2-(n-substituierte guanidino)-4heteroarylthiazole als mittel gegen geschwuere.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: KROHER, STROBEL RECHTS- UND PATENTANWAELTE, 80336

8328 Change in the person/name/address of the agent

Representative=s name: DR. SCHOEN & PARTNER, 80336 MUENCHEN